HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jorge R Georgakopoulos Selected Research
Jorge R Georgakopoulos Research Topics
Disease
17
Psoriasis (Pustulosis Palmaris et Plantaris)
04/2024 - 09/2017
9
Atopic Dermatitis (Atopic Eczema)
12/2023 - 06/2020
5
COVID-19
05/2022 - 07/2020
4
Vitiligo
03/2024 - 03/2021
2
Infections
11/2023 - 11/2023
2
Psoriatic Arthritis
07/2022 - 08/2020
1
Hidradenitis Suppurativa
11/2023
1
Dermatomyositis (Dermatopolymyositis)
11/2023
1
Skin Diseases (Skin Disease)
01/2023
1
Asthma (Bronchial Asthma)
05/2022
1
Chronic Urticaria
05/2022
1
Uveitis
01/2022
1
Prurigo
10/2021
1
Erythema
05/2021
1
Conjunctivitis
09/2020
1
Neoplasms (Cancer)
08/2020
1
Herpes Zoster
08/2020
1
Thrombosis (Thrombus)
08/2020
1
Pyoderma Gangrenosum
11/2018
1
Inflammation (Inflammations)
05/2018
Drug/Important Bio-Agent (IBA)
10
dupilumab
IBA
12/2023 - 06/2020
6
Janus Kinase Inhibitors
IBA
11/2023 - 08/2020
5
apremilast
IBA
07/2020 - 01/2018
5
secukinumab
IBA
07/2019 - 01/2018
2
Immune Checkpoint Inhibitors
IBA
03/2024 - 10/2023
2
upadacitinib
IBA
12/2023 - 11/2022
2
Omalizumab (Xolair)
FDA Link
05/2022 - 09/2020
2
Adalimumab (Humira)
FDA Link
01/2022 - 08/2020
2
ixekizumab
IBA
03/2019 - 07/2018
1
bimekizumab
IBA
04/2024
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2024
1
risankizumab
IBA
09/2023
1
Interleukin-23 (Interleukin 23)
IBA
09/2023
1
guselkumab
IBA
09/2023
1
Interleukin Inhibitors
IBA
03/2023
1
Infliximab (Remicade)
FDA Link
01/2022
1
tofacitinib
IBA
08/2020
1
Janus Kinases
IBA
08/2020
1
Monoclonal Antibodies
IBA
07/2019
1
Rituximab (Mabthera)
FDA Link
11/2018
1
Interleukin-17 (Interleukin 17)
IBA
07/2018
1
Prostaglandins A
IBA
05/2018
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
05/2018
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
09/2017
Therapy/Procedure
7
Therapeutics
10/2023 - 01/2018
3
Biological Therapy
07/2022 - 10/2020